690P Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study
Authors:
- M.R. PatelMPM.R. Patel
- T. DoiTDT. Doi
- T. KoyamaTKT. Koyama
- G.S. FalchookGFG.S. Falchook
- C.F. FriedmanCFC.F. Friedman
- S.A. Piha-PaulSPS.A. Piha-Paul
- M. GutierrezMGM. Gutierrez
- M.M. AwadMAM.M. Awad
- A.H. MattourAMA.H. Mattour
- T. SatohTST. Satoh
- N. OkamotoNON. Okamoto
- J. SinghJSJ. Singh
- 20 October 2023
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 34, S481-S482